THC vs EHC stock comparison
Tenet Healthcare vs. Encompass Health · data as of November 13, 2026
Tenet Healthcare (THC) has a market value of about $22.8B, Encompass Health (EHC) about $13.8B. Over their latest twelve months Tenet Healthcare had revenue of $22.2B and Encompass Health $6.3B.
On our five checks Encompass Health scores higher: 3.6 out of 5 (good) against 2.8 (average).
By area, the stronger company is Tenet Healthcare on value; Encompass Health on future growth; Encompass Health on track record; Encompass Health on financial health; Encompass Health on shareholder returns.
Tenet Healthcare is cheaper on earnings (P/E 8.3 vs. 22.0), while Encompass Health grew revenue faster over five years (10.7% vs. 3.9% a year).
Tenet Healthcare leads on 14 of the compared lines and Encompass Health on 10.
Side by side
| THC | EHC | |
|---|---|---|
| Size and price | ||
| Market cap | $22.8B | $13.8B |
| Share price | $286.03 | $140.99 |
| Score | ||
| Overall score (of 5) | 2.8 | 3.6 |
| Value | 5 | 2 |
| Future growth | 1 | 4 |
| Track record | 4 | 5 |
| Financial health | 1 | 3 |
| Shareholder returns | 3 | 4 |
| Valuation | ||
| P/E (TTM) | 8.3 | 22.0 |
| Forward P/E | 14.3 | 20.9 |
| Price / free cash flow | 6.8 | 30.3 |
| Price / sales | 1.0 | 2.2 |
| EV / EBITDA | 5.3 | 10.7 |
| PEG | 0.25 | 1.55 |
| DCF value vs. price | +31% | −46% |
| Business | ||
| Revenue | $22.2B | $6.3B |
| Net income | $2.9B | $644M |
| Free cash flow | $3.3B | $457M |
| Net margin | 13.1% | 10.2% |
| Gross margin (5-yr avg.) | — | — |
| ROIC (5-yr avg.) | 14.9% | 12.2% |
| Growth | ||
| Revenue growth (1 yr) | 3.1% | 10.5% |
| Revenue growth (5 yrs, per year) | 3.9% | 10.7% |
| EPS growth (5 yrs, per year) | 32.8% | 14.2% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$10.6B | -$2.7B |
| Dividend yield | None | 0.60% |
| Shareholder yield | 6.1% | 1.7% |
| Analysts | ||
| Upside to average target | +8% | +11% |
| Consensus rating | Buy | Strong buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: THC TTM to September 30, 2026, EHC TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Tenet Healthcare or Encompass Health?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Encompass Health scores 3.6 out of 5 and Tenet Healthcare 2.8; the table shows where each one is stronger.
Is Tenet Healthcare cheaper than Encompass Health?
On trailing earnings, Tenet Healthcare trades at a P/E of 8.3 and Encompass Health at 22.0, so Tenet Healthcare is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Tenet Healthcare or Encompass Health?
Over five years Encompass Health grew revenue about 10.7% a year and Tenet Healthcare about 3.9% a year.
Which pays a higher dividend?
Tenet Healthcare yields nothing (no dividend) and Encompass Health 0.60%.
Full Tenet Healthcare analysis → Full Encompass Health analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.